Results 221 to 230 of about 232,968 (298)
Beyond the bowel: novel comorbidity patterns in inflammatory bowel disease from the all of us research program. [PDF]
Sudhakaran SC +5 more
europepmc +1 more source
The Role of Inflammation in Infant Colic—A Systematic Review and Meta‐Analysis
ABSTRACT Aim Despite being a self‐limiting condition, infant colic is associated with negative consequences for caregivers and infants. Gut inflammation is hypothesised as a contributing factor. We collected and meta‐analysed the most recent evidence on the association between infant colic and gut inflammation.
Dan Boëtius Andersen +8 more
wiley +1 more source
The role of extracellular vesicles in the transport and regulation of novel inflammatory mediators in IBD and its associated CRC. [PDF]
Zhang C +4 more
europepmc +1 more source
Importance of psychosocial support. ABSTRACT Aim The aim of this scoping review was to identify, examine, and summarize available evidence regarding psychosocial supports provided to children with a chronic disease when admitted to hospital and their parents. Method The JBI methodology for conducting and reporting scoping reviews was followed.
Lyndsay Jerusha MacKay +6 more
wiley +1 more source
A Bidirectional Analysis of Inflammatory Bowel Disease and Gout: Epidemiologic Evidence of a Stronger Association in Crohn's Disease from a Nationwide Cohort Study in South Korea. [PDF]
Yoo DM +7 more
europepmc +1 more source
The results of a geriatric assessment in older patients with IBD were associated with adverse health outcomes. Frailty, reflected by severe deficits in geriatric assessment, was independently associated with all‐cause and acute hospitalisations in older patients with IBD. ABSTRACT Background Guidelines recommend considering frailty in the management of
Anne B. Fons +10 more
wiley +1 more source
Post-inflammatory polyps and risk of dysplasia in inflammatory bowel disease: Wolves in sheep's clothing? [PDF]
De Cristofaro E +3 more
europepmc +1 more source
One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
In a real‐world cohort of patients with highly refractory perianal Crohn's disease, upadacitinib induced clinical remission at 12 months in 26% of patients with fistulizing disease and 25% of those with isolated anal ulcerations. ABSTRACT Introduction Upadacitinib (UPA) is effective for treating luminal Crohn's disease (CD), but data on perianal CD ...
Nicolas Richard +13 more
wiley +1 more source
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser +12 more
wiley +1 more source

